ConductScience.org, home

Paper · 39741663

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135400496Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis.Atherosclerosis2022https://conductscience.org/library/papers/35400496PubMed
223868944
Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Arterioscler Thromb Vasc Biol2013https://conductscience.org/library/papers/23868944PubMed
334356845Inflammatory Mechanisms Contributing to Endothelial Dysfunction.Biomedicines2021https://conductscience.org/library/papers/34356845PubMed
419195607Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.J Am Coll Cardiol2009https://conductscience.org/library/papers/19195607PubMed
536799940Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.Eur J Prev Cardiol2023https://conductscience.org/library/papers/36799940PubMed
637522848Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy.Endocr Connect2023https://conductscience.org/library/papers/37522848PubMed
719955250Chronic coronary artery disease: diagnosis and management.Mayo Clin Proc2009https://conductscience.org/library/papers/19955250PubMed
831446075New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.J Mol Biol2020https://conductscience.org/library/papers/31446075PubMed
924267262Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice.Atherosclerosis2013https://conductscience.org/library/papers/24267262PubMed
1026630143Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.N Engl J Med2015https://conductscience.org/library/papers/26630143PubMed
1131447282Inflammation in atherosclerosis: A key role for cytokines.Cytokine2019https://conductscience.org/library/papers/31447282PubMed
1227110066Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.Mediators Inflamm2016https://conductscience.org/library/papers/27110066PubMed
1315616022Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.Diabetes2005https://conductscience.org/library/papers/15616022PubMed
1420068138Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.Diabetes2010https://conductscience.org/library/papers/20068138PubMed
1536317383Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors.Coron Artery Dis2023https://conductscience.org/library/papers/36317383PubMed
1631002893GLP-1: Molecular mechanisms and outcomes of a complex signaling system.Neurochem Int2019https://conductscience.org/library/papers/31002893PubMed
1730291013Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.Lancet2018https://conductscience.org/library/papers/30291013PubMed
1831270216Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.J Pharmacol Exp Ther2019https://conductscience.org/library/papers/31270216PubMed
1926447224The physiological role of glucagon-like peptide-1 in the regulation of renal function.Am J Physiol Renal Physiol2016https://conductscience.org/library/papers/26447224PubMed
2031185157Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med2019https://conductscience.org/library/papers/31185157PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/39741663/references